Literature DB >> 18680162

Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.

Cécile Colavolpe1, Eric Guedj, Serge Cammilleri, David Taïeb, Olivier Mundler, Carole Coze.   

Abstract

We report on the case of a 10-month-old female infant with a metastatic neuroblastoma which became MIBG-negative at time of relapse. We discuss the different hypothesis associated with this particular outcome, and the potential utility of FDG-PET as an alternative to follow up the residual disease at this stage.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18680162     DOI： 10.1002/pbc.21594

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  9 in total

1.  Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

2.  Guidelines on nuclear medicine imaging in neuroblastoma.

Authors:  Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10       Impact factor: 9.236

3.  ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Authors:  Henriette Ingrid Melzer; Eva Coppenrath; Irene Schmid; Michael H Albert; Dietrich von Schweinitz; Coral Tudball; Peter Bartenstein; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-27       Impact factor: 9.236

4.  Value of FDG-PET/CT examinations in different cancers of children, focusing on lymphomas.

Authors:  Edit Bárdi; Mónika Csóka; Ildikó Garai; István Szegedi; Judit Müller; Tamás Györke; Kornélia Kajáry; Karolina Nemes; Csongor Kiss; Gábor Kovács
Journal:  Pathol Oncol Res       Date:  2013-08-17       Impact factor: 3.201

Review 5.  Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Authors:  Wolfgang Peter Mueller; Eva Coppenrath; Thomas Pfluger
Journal:  Pediatr Radiol       Date:  2012-11-14

6.  Clinical experience with (18)F-fluorodeoxyglucose positron emission tomography and (123)I-metaiodobenzylguanine scintigraphy in pediatric neuroblastoma: complementary roles in follow-up of patients.

Authors:  Tae Young Gil; Do Kyung Lee; Jung Min Lee; Eun Sun Yoo; Kyung-Ha Ryu
Journal:  Korean J Pediatr       Date:  2014-06-30

Review 7.  Molecular imaging of adrenal neoplasms.

Authors:  Clara C Chen; Jorge A Carrasquillo
Journal:  J Surg Oncol       Date:  2012-05-24       Impact factor: 2.885

8.  Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy.

Authors:  Yuya Sato; Hidemitsu Kurosawa; Setsu Sakamoto; Shigeko Kuwashima; Teisuke Hashimoto; Kentaro Okamoto; Takashi Tsuchioka; Keitaro Fukushima; Osamu Arisaka
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 9.  Lymph node imaging of pediatric renal and suprarenal malignancies.

Authors:  Samuel A Gold; Vikram K Sabarwal; Chirag Gordhan; Graham R Hale; Andrew Winer
Journal:  Transl Androl Urol       Date:  2018-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.